About: Argenica Therapeutics Limited, a biotechnology company, engages in the research and development of neuroprotective therapeutic drugs in Australia. Its lead product candidate is ARG-007, a neuroprotective peptide candidate, which is in phase 2 clinical trial to reduce brain tissue death after stroke and other types of brain injury. Argenica Therapeutics Limited was incorporated in 2019 and is based in Nedlands, Australia.
Sector: Healthcare
Industry: Biotechnology
Latest price: A$0.13 (+4.00%)
AGN ASX Argenica Therapeutics Ltd
Argenica Therapeutics Ltd share price
AGN price activity
Último preço
$ 0,130
Variação (24h)
0,01 AUD (4,00%)
Volume
8.01K
Volume (média 4 sem.)
-
Abertura
$ 0,13
Variação do dia
$ 0,13 - $ 0,13
Fechamento anterior
$ 0,13
Último negócio
07 Oct, 3:08 am GMT+0
Atrasado
07 Oct, 3:08 am GMT+0
AGN price performance
Atrasado
07 Oct, 3:08 am GMT+0
quote.marketSignals